Watch Ticker

Intra-Cellular Therapies Inc.

Go to Intra-Cellular Therapies Inc. Website

$131.87

(%)

Live

Previous Close

$131.87

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - CAPLYTA’s Strong Market Adoption Propels Its Rise as a Leading Antipsychotic Therapy | DelveInsight

Intra-Cellular Therapies' CAPLYTA, an antipsychotic drug, is gaining traction in the market for treating schizophrenia and bipolar depression, with its differentiated safety profile and broad efficacy.

Related tickers: ITCI, JNJ, BMY, CELGr.

Read Full Article

Intra-Cellular Therapies, Inc. - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Intra-Cellular Therapies reported strong financial results for Q4 2024, with CAPLYTA net product sales growing 51% year-over-year. The company also announced the FDA's acceptance of a supplemental New Drug Application for CAPLYTA as an adjunctive treatment for major depressive disorder.

Related tickers: ITCI.

Read Full Article

Trending Tickers

Please sign in to view